Irisin and Cardiometabolic Disorders in Obesity: A Systematic Review.
Jorge da Silva Pinho-JrFlávio Andrade CamachoCarollyne Dos Santos CavararoPaula Ferreira BaiãoRenata Frauches MedeirosSérgio Girão BarrosoAndrea Cardoso de MatosPublished in: International journal of inflammation (2023)
The review suggests that irisin plays a significant role as both a preventive measure and a biomarker for comorbidities linked to obesity and cardiometabolic disorders. Future research should focus on standardized irisin measurement methods and diverse populations to further elucidate its mechanisms of action.